Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02657005
Title TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tokalas, Inc.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
Children's Hospital of Colorado Aurora Colorado 80045 United States Details
Children's National Hospital Washington District of Columbia 20010 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10174 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Texas Children's Cancer & Hematology Centers, Baylor College Houston Texas 77030 United States Details
UT MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field